Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

Item
http://www.wikidata.org/entity/Q57417579
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusCardiac safety of ophthalmic timolol.Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholytics.Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects.Emerging drugs for ocular hypertension.Novel drug delivery systems for glaucoma.Microemulsion: new insights into the ocular drug delivery.Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.Effect of potassium channel openers in acute and chronic models of glaucoma.Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.Effects of selective serotonin reuptake inhibitors on timolol metabolism in human liver microsomes and cryo-preserved hepatocytes.
P2860

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

Item
http://www.wikidata.org/entity/Q57417579
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2006
@uk
name
Improved systemic safety and r ...... n in the treatment of glaucoma
@en
Improved systemic safety and r ...... n in the treatment of glaucoma
@nl
type
label
Improved systemic safety and r ...... n in the treatment of glaucoma
@en
Improved systemic safety and r ...... n in the treatment of glaucoma
@nl
prefLabel
Improved systemic safety and r ...... n in the treatment of glaucoma
@en
Improved systemic safety and r ...... n in the treatment of glaucoma
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Improved systemic safety and r ...... n in the treatment of glaucoma
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P921